Reference number : 172-2018-2019-Q3-914177, amendment number : , agreement type : C, recipient legal name : Microbix Biosystems Inc., recipient country : CA, recipient province : ON, recipient city : Mississauga|Mississauga, recipient postal code : L4Z 1P3, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Rubella BR2s Downstream Process Streamlining, agreement title french : Rationalisation des processus en aval de rubéole BR2, agreement number : 914177, agreement value : 249500.0, agreement start date : 2018-09-03, agreement end date : 2019-03-31, description english : Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by developing and implementing a new, automated bioreactor production platform for production of Rubella virus, its largest and fasted growing product line.  Customers around the world, have provided good feedback and have begun transition of their regulated medical devices to use Microbix’ bioreactor product. As a consequence of this customer demand, Microbix will initiate a new project to debottleneck and streamline the purification process: to reduce process steps, increase step automation and to introduce new process control test methodologies., description french : Rationalisation des processus en aval de rubéole BR2, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada